GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.

Por Zekzer, D, Wong, F S, Ayalon, O, Millet, I, Altieri, M, Shintani, S, Solimena, M, Sherwin, R S
Publicado em 1998

Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy

Por Basadonna, G. P., Auersvald, L., Khuong, C. Q., Zheng, X. X., Kashio, N., Zekzer, D., Minozzo, M., Qian, H.-Y., Visser, L., Diepstra, A., Lazarovits, A. I., Poppema, S., Strom, T. B., Rothstein, D. M.
Publicado em 1998